Department of Molecular, Cell and Cancer Biology
Cancer Biology | Cell Biology | Hemic and Lymphatic Diseases | Neoplasms | Oncology
Acute myeloid leukemia (AML) is a collection of hematologic malignancies with specific driver mutations that direct the pathology of the disease. The understanding of the origin and function of these mutations at early stages of transformation is critical to understand the etiology of the disease and for the design of effective therapies. The chromosome inversion inv(16) is thought to arise as a founding mutation in a hematopoietic stem cell (HSC) to produce preleukemic HSCs (preL-HSCs) with myeloid bias and differentiation block, and predisposed to AML. Studies in mice and human AML cells have established that inv(16) AML follows a clonal evolution model, in which preL-HSCs expressing the fusion protein CBFbeta-SMMHC persist asymptomatic in the bone marrow. The emerging leukemia-initiating cells (LICs) are composed by the inv(16) and a heterogeneous set of mutations. In this review, we will discuss the current understanding of inv(16) preleukemia development, and the function of CBFbeta-SMMHC related to preleukemia progression and LIC activity. We also discuss important open mechanistic questions in the etiology of inv(16) AML.
CBFB-MYH11, CBFβ-SMMHC, clonal evolution, leukemia, leukemia-initiating cell, myeloid, preleukemia, stem cells
Rights and Permissions
Copyright © 2018 Pulikkan and Castilla. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
DOI of Published Version
Front Oncol. 2018 Apr 26;8:129. doi: 10.3389/fonc.2018.00129. eCollection 2018. Link to article on publisher's site
Frontiers in oncology
Pulikkan JA, Castilla LH. (2018). Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia. Open Access Publications by UMass Chan Authors. https://doi.org/10.3389/fonc.2018.00129. Retrieved from https://escholarship.umassmed.edu/oapubs/3434
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.